Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Ascentage Pharma Group Inc.
Scientific Title
A Phase Ib /II Open-label, Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (MAPLE-1)